KAYLEE COFFMAN: Open Payments
NPI 1518537588 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,131 in 173 payments from 32 companies in 2025. Trend: 2023 $1,572 · 2024 $3,195 · 2025 $4,131
Food & beverage: $4,131
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 26 | $665 |
| Medtronic, Inc. | 19 | $639 |
| SANOFI-AVENTIS U.S. LLC | 9 | $228 |
| Abbott Laboratories | 11 | $223 |
| Astellas Pharma US Inc | 7 | $205 |
| Neurocrine BioSciences, Inc. | 7 | $201 |
| Amgen Inc. | 11 | $187 |
| Mannkind Corporation | 11 | $182 |
| Ascendis Pharma Endocrinology Inc | 7 | $174 |
| Soleno Therapeutics, Inc. | 5 | $149 |
Products named: MINIMED 780G, Ozempic, TZIELD, Veozah, FREESTYLE LIBRE 3, CRENESSITY, AFREZZA, Yorvipath.
Industry payments across TX — which companies pay providers there.
